: IBM nears deal to buy software company Apptio for $5 billion: WSJ
IBM is close to a deal to buy cloud-based business software company Apptio for more than double its purchase price five years ago, the WSJ...
: IBM nears deal to buy software company Apptio for $5 billion: WSJ
International Business Machines Co. IBM is close to a deal to buy cloud-based business software company Apptio Inc. for more than double its purchase price...
The Ratings Game: Could Uber’s stock cruise to $70? Barclays thinks it can keep riding higher in a big way.
Uber shares have been on a tear this year, but Barclays analyst Ross Sandler sees ample room for the dominant ride-hailing name to continue cruising.
: As I-95 reopens, FedEx says section collapse has had ‘minimal’ impact on its operation
The collapse of an elevated section of Interstate 95 in Philadelphia sparked fears of a monthslong traffic snarl.
IPO Report: Sagimet Biosciences gives going public a second chance under new CEO
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday.
: Beauty shopping platform Oddity Tech files for IPO
Oddity Tech Ltd., a beauty and wellness-focused shopping platform, filed for an initial public offering on Friday, with hopes of using a more tech-centric approach...
: Elon Musk’s SpaceX eyeing $150 billion valuation: reports
Elon Musk’s SpaceX seeks to increase its valuation to $150 billion, The Wall Street Journal reported late Friday, citing people familiar with the issue. The...
: Sagimet Biosciences gives going public a second chance under new CEO
Biotech drug developer Sagimet Biosciences is giving it another shot to take itself public, according to a filing with the Securities and Exchange Commission late...
: Pfizer’s alopecia drug for teens and adults approved by FDA
Pfizer Inc. PFE said late Friday that its drug ritlecitinib, sold under the brand name of Litfulo, has been approved by the U.S. Food and...